Masimo Change in Accounts Receivable 2010-2025 | MASI

Masimo change in accounts receivable for the twelve months ending June 30, 2025 was $-0.099B, a 167.14% decline year-over-year.

  • Masimo annual change in accounts receivable for 2024 was $-0.073B, a 180.82% decline from 2023.
  • Masimo annual change in accounts receivable for 2023 was $0.09B, a 165.13% decline from 2022.
  • Masimo annual change in accounts receivable for 2022 was $-0.139B, a 127.8% increase from 2021.

Masimo Change in Accounts Receivable 2010-2025 | MASI

  • Masimo annual change in accounts receivable for 2024 was $-0.073B, a 180.82% decline from 2023.
  • Masimo annual change in accounts receivable for 2023 was $0.09B, a 165.13% decline from 2022.
  • Masimo annual change in accounts receivable for 2022 was $-0.139B, a 127.8% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$186.1B
Intuitive Surgical (ISRG)$169.7B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.8B
Alcon (ALC)$39.4B
IQVIA Holdings (IQV)$32.4B
DexCom (DXCM)$29.5B
Mettler-Toledo (MTD)$26.8B
STERIS (STE)$24.1B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.4B
Hologic (HOLX)$14.9B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$7.9B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Veracyte (VCYT)$2.4B
Alphatec Holdings (ATEC)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B